Antimicrobial Resistance Trends of the Most Common Causative Pathogens Associated with Community-acquired Respiratory Infections in China: 2009–2018
暂无分享,去创建一个
Xiaojuan Wang | Hongbin Chen | Yawei Zhang | Chun-jiang Zhao | Henan Li | Fei-fei Zhang | Zhan-wei Wang | Hui Wang | Shuo Yang
[1] Jie Tian,et al. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine on All-Cause Pneumonia in Children Under 5 Years in Shanghai, China: A Real-World Study , 2022, SSRN Electronic Journal.
[2] B. Gessner,et al. Effectiveness of 13-valent pneumococcal conjugate vaccine against community acquired pneumonia among children in China, an observational cohort study. , 2021, Vaccine.
[3] E. Motonaga,et al. Clinical characteristics of community-acquired pneumonia due to Moraxella catarrhalis in adults: a retrospective single-centre study , 2020, BMC Infectious Diseases.
[4] Qi Wang,et al. Investigation of Antibiotic Resistance, Serotype Distribution, and Genetic Characteristics of 164 Invasive Streptococcus pneumoniae from North China Between April 2016 and October 2017 , 2020, Infection and drug resistance.
[5] A. Davis,et al. Diagnosis and Treatment of Adults With Community-Acquired Pneumonia. , 2020, JAMA.
[6] M. Ip,et al. Antibiotic-Resistant Community-Acquired Bacterial Pneumonia. , 2019, Infectious disease clinics of North America.
[7] M. Fine,et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America , 2019, American journal of respiratory and critical care medicine.
[8] Yonghong Xiao. Antimicrobial Stewardship in China: Systems, Actions and Future Strategies. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] B. Cao,et al. Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016). , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] Juan Yang,et al. The landscape of vaccines in China: history, classification, supply, and price , 2018, BMC Infectious Diseases.
[11] J. Hinds,et al. Carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Indonesian children: A cross-sectional study , 2018, PloS one.
[12] J. Gerber,et al. Macrolides in Children With Community-Acquired Pneumonia: Panacea or Placebo? , 2018, Journal of the Pediatric Infectious Diseases Society.
[13] B. Cao,et al. Diagnosis and treatment of community‐acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association , 2017, The clinical respiratory journal.
[14] B. Cao,et al. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016 , 2017, BMC Infectious Diseases.
[15] K. Huh,et al. Community-Acquired Pneumonia in the Asia-Pacific Region , 2016, Seminars in Respiratory and Critical Care Medicine.
[16] K. Bush,et al. β-Lactams and β-Lactamase Inhibitors: An Overview. , 2016, Cold Spring Harbor perspectives in medicine.
[17] C. D. Dela Cruz,et al. Pneumococcal Vaccination Strategies. An Update and Perspective. , 2016, Annals of the American Thoracic Society.
[18] B. Cao,et al. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program. , 2016, Journal of global antimicrobial resistance.
[19] A. Pantosti,et al. Antimicrobial resistance: a global multifaceted phenomenon , 2015, Pathogens and global health.
[20] J. Campos,et al. Isolates of β-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem. , 2014, The Journal of antimicrobial chemotherapy.
[21] Ulysses W. Sallum,et al. Rapid optical determination of β-lactamase and antibiotic activity , 2014, BMC Microbiology.
[22] B. Thakuria,et al. The Beta Lactam Antibiotics as an Empirical Therapy in a Developing Country: An Update on Their Current Status and Recommendations to Counter the Resistance against Them. , 2013, Journal of clinical and diagnostic research : JCDR.
[23] B. Cao,et al. Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010. , 2011, International journal of antimicrobial agents.
[24] Y. Li,et al. Molecular characterization of erm(B)‐ and mef(E)‐mediated erythromycin‐resistant Streptococcus pneumoniae in China and complete DNA sequence of Tn2010 , 2011, Journal of applied microbiology.
[25] Hadley Wickham,et al. ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .
[26] M. Kaku,et al. Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-5 (1999-2004). , 2008, Microbial drug resistance.
[27] Samir N. Patel,et al. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline , 2006 .
[28] Li Youning,et al. Resistance Phenotypes and Genotypes of Erythromycin-Resistant Streptococcus pneumoniae Isolates in Beijing and Shenyang, China , 2004, Antimicrobial Agents and Chemotherapy.
[29] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[30] J. Waitz. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .
[31] K J Ryan,et al. Antimicrobial Susceptibility Testing , 2016, Advances in Experimental Medicine and Biology.